Lactococcus lactis NCDO2118 exerts visceral antinociceptive properties in rat via GABA production in the gastro-intestinal tract

Gut disorders associated to irritable bowel syndrome (IBS) are combined with anxiety and depression. Evidence suggests that microbially produced neuroactive molecules, like γ-aminobutyric acid (GABA), can modulate the gut-brain axis. Two natural strains of Lactococcus lactis and one mutant were characterized in vitro for their GABA production and tested in vivo in rat by oral gavage for their antinociceptive properties. L. lactis NCDO2118 significantly reduced visceral hypersensitivity induced by stress due to its glutamate decarboxylase (GAD) activity. L. lactis NCDO2727 with similar genes for GABA metabolism but no detectable GAD activity had no in vivo effect, as well as the NCDO2118 ΔgadB mutant. The antinociceptive effect observed for the NCDO2118 strain was mediated by the production of GABA in the gastro-intestinal tract and blocked by GABAB receptor antagonist. Only minor changes in the faecal microbiota composition were observed after the L. lactis NCDO2118 treatment. These findings reveal the crucial role of the microbial GAD activity of L. lactis NCDO2118 to deliver GABA into the gastro-intestinal tract for exerting antinociceptive properties in vivo and open avenues for this GRAS (Generally Recognized As safe) bacterium in the management of visceral pain and anxious profile of IBS patients.

[1]  Alexander T. M. Fisch,et al.  A linear time method for the detection of collective and point anomalies , 2022, Stat. Anal. Data Min..

[2]  Alexander V. Zhdanov,et al.  The gut microbiome influences the bioavailability of olanzapine in rats , 2021, EBioMedicine.

[3]  Y. Le Loir,et al.  Therapeutic Effects of Probiotic Minas Frescal Cheese on the Attenuation of Ulcerative Colitis in a Murine Model , 2021, Frontiers in Microbiology.

[4]  P. Loubière,et al.  Environmental Conditions Affecting GABA Production in Lactococcus lactis NCDO 2118 , 2021, Microorganisms.

[5]  Donovan H. Parks,et al.  A complete domain-to-species taxonomy for Bacteria and Archaea , 2020, Nature Biotechnology.

[6]  F. Shanahan,et al.  Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption. , 2019, Gastroenterology.

[7]  Karsten Zengler,et al.  GABA Modulating Bacteria of the Human Gut Microbiota , 2018, Nature Microbiology.

[8]  Mahendra Mariadassou,et al.  FROGS: Find, Rapidly, OTUs with Galaxy Solution , 2018, Bioinform..

[9]  C. Knauf,et al.  Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917 , 2017, Nature Communications.

[10]  M. Cocaign-Bousquet,et al.  From Genome to Phenotype: An Integrative Approach to Evaluate the Biodiversity of Lactococcus lactis , 2017, Microorganisms.

[11]  N. Oezguen,et al.  Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome , 2017, Microbiome.

[12]  V. Azevedo,et al.  Analyses of the probiotic property and stress resistance-related genes of Lactococcus lactis subsp. lactis NCDO 2118 through comparative genomics and in vitro assays , 2017, PloS one.

[13]  B. Strukelj,et al.  Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of Tumor necrosis Factor &agr; , 2017, International immunopharmacology.

[14]  R. Yunes,et al.  GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota. , 2016, Anaerobe.

[15]  R. Mazzoli,et al.  The Neuro-endocrinological Role of Microbial Glutamate and GABA Signaling , 2016, Front. Microbiol..

[16]  R. P. Ross,et al.  Streptococcus thermophilus APC151 Strain Is Suitable for the Manufacture of Naturally GABA-Enriched Bioactive Yogurt , 2016, Front. Microbiol..

[17]  P. Loubière,et al.  Adhesion of the genome-sequenced Lactococcus lactis subsp. cremoris IBB477 strain is mediated by specific molecular determinants , 2016, Applied Microbiology and Biotechnology.

[18]  Marian Joëls,et al.  Brain GABA levels across psychiatric disorders: A systematic literature review and meta‐analysis of 1H‐MRS studies , 2016, Human brain mapping.

[19]  M. Vicario,et al.  Mechanisms of Stress‐Induced Visceral Pain: Implications in Irritable Bowel Syndrome , 2016, Journal of neuroendocrinology.

[20]  N. Oezguen,et al.  GABA‐producing Bifidobacterium dentium modulates visceral sensitivity in the intestine , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[21]  P. Loubière,et al.  GABA Production in Lactococcus lactis Is Enhanced by Arginine and Co-addition of Malate , 2016, Front. Microbiol..

[22]  Johan E T van Hylckama Vlieg,et al.  Ecological robustness of the gut microbiota in response to ingestion of transient food-borne microbes , 2016, The ISME Journal.

[23]  David C. Gondek,et al.  Impact of probiotic supplements on microbiome diversity following antibiotic treatment of mice , 2016, Gut microbes.

[24]  P. Enck,et al.  Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It? , 2015, Journal of neurogastroenterology and motility.

[25]  Hongzhe Li,et al.  Power and sample-size estimation for microbiome studies using pairwise distances and PERMANOVA , 2015, Bioinform..

[26]  W. Garrett,et al.  Host lysozyme-mediated lysis of Lactococcus lactis facilitates delivery of colitis-attenuating superoxide dismutase to inflamed colons , 2015, Proceedings of the National Academy of Sciences.

[27]  C. Fraser,et al.  Functional Dynamics of the Gut Microbiome in Elderly People during Probiotic Consumption , 2015, mBio.

[28]  S. Nikfar,et al.  Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. , 2015, World journal of gastroenterology.

[29]  M. Zizzo,et al.  GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation. , 2015, Pharmacological research.

[30]  A. Miyoshi,et al.  Genome Sequence of Lactococcus lactis subsp. lactis NCDO 2118, a GABA-Producing Strain , 2014, Genome Announcements.

[31]  P. Moayyedi,et al.  Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis , 2014, The American Journal of Gastroenterology.

[32]  D. C. Cara,et al.  Anti-inflammatory effects of Lactococcus lactis NCDO 2118 during the remission period of chemically induced colitis , 2014, Gut Pathogens.

[33]  P. Whorwell,et al.  Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice – an evidence-based international guide , 2013, Alimentary pharmacology & therapeutics.

[34]  Paul J. McMurdie,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[35]  D. Drossman,et al.  The use of psychotropic drugs in irritable bowel syndrome , 2013, Expert opinion on investigational drugs.

[36]  K. Karatzas,et al.  Role of glutamate metabolism in bacterial responses towards acid and other stresses , 2013, Journal of applied microbiology.

[37]  Pelin Yilmaz,et al.  The SILVA ribosomal RNA gene database project: improved data processing and web-based tools , 2012, Nucleic Acids Res..

[38]  Nicholas A. Bokulich,et al.  Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing , 2012, Nature Methods.

[39]  Seth D. Crockett,et al.  Burden of gastrointestinal disease in the United States: 2012 update. , 2012, Gastroenterology.

[40]  M. Camilleri,et al.  Irritable bowel syndrome: methods, mechanisms, and pathophysiology. The confluence of increased permeability, inflammation, and pain in irritable bowel syndrome. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[41]  T. Dinan,et al.  Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour , 2012, Nature Reviews Neuroscience.

[42]  K. Baek,et al.  Production of gaba (γ – Aminobutyric acid) by microorganisms: a review , 2012, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[43]  J. Fichna,et al.  Brain-Gut Interactions in IBS , 2012, Front. Pharmacol..

[44]  Yigong Shi,et al.  Structure and mechanism of a glutamate–GABA antiporter , 2012, Nature.

[45]  Yanping Wang,et al.  Use of GFP to trace the colonization of Lactococcus lactis WH-C1 in the gastrointestinal tract of mice. , 2011, Journal of microbiological methods.

[46]  T. Dinan,et al.  Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve , 2011, Proceedings of the National Academy of Sciences.

[47]  Mark Lyte,et al.  Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[48]  G. Reid.  Neuroactive probiotics , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[49]  J. Cryan,et al.  The microbiome‐gut‐brain axis: from bowel to behavior , 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[50]  J. Cryan,et al.  A Gut Feeling about GABA: Focus on GABAB Receptors , 2010, Front. Pharmacol..

[51]  R. P. Ross,et al.  The changing face of dairy starter culture research: from genomics to economics. , 2010 .

[52]  Haixing Li,et al.  Lactic acid bacterial cell factories for gamma-aminobutyric acid , 2010, Amino Acids.

[53]  P. Loubière,et al.  Glutamate-induced metabolic changes in Lactococcus lactis NCDO 2118 during GABA production: combined transcriptomic and proteomic analysis , 2010, Amino Acids.

[54]  M. Mizuno,et al.  Lactococcus lactis subsp. cremoris FC alleviates symptoms of colitis induced by dextran sulfate sodium in mice. , 2009, International immunopharmacology.

[55]  P. Moayyedi,et al.  The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review , 2008, Gut.

[56]  J. Kemp,et al.  Glutamate- and GABA-based CNS therapeutics. , 2006, Current opinion in pharmacology.

[57]  B. Dean,et al.  Impairment in work productivity and health-related quality of life in patients with IBS. , 2005, The American journal of managed care.

[58]  Y. Yamori,et al.  Effect of a γ-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar–Kyoto rats , 2004, British Journal of Nutrition.

[59]  V. Martínez,et al.  Peripheral GABAB agonists stimulate gastric acid secretion in mice , 2004, British journal of pharmacology.

[60]  S. Salminen,et al.  Permanent Colonization by Lactobacillus casei Is Hindered by the Low Rate of Cell Division in Mouse Gut , 2004, Applied and Environmental Microbiology.

[61]  E. Osmanoglou,et al.  Role of Stress in Functional Gastrointestinal Disorders , 2001, Digestive Diseases.

[62]  H. Ueno.  Enzymatic and structural aspects on glutamate decarboxylase , 2000 .

[63]  N. D. de Wit,et al.  The use of consensus to develop guidelines for the management of Helicobacter pylori infection in primary care. European Society for Primary Care Gastroenterology. , 2000, Family practice.

[64]  G. Gessa,et al.  Distribution of GABA(B) receptor mRNAs in the rat brain and peripheral organs. , 1999, Life sciences.

[65]  R. Satokari,et al.  Persistence of Colonization of Human Colonic Mucosa by a Probiotic Strain, Lactobacillus rhamnosusGG, after Oral Consumption , 1999, Applied and Environmental Microbiology.

[66]  V. Théodorou,et al.  Stress‐induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells , 1997, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[67]  S. Ehrlich,et al.  Efficient insertional mutagenesis in lactococci and other gram-positive bacteria , 1996, Journal of bacteriology.

[68]  L. Buéno,et al.  Influence of 5‐HT3 receptor antagonists in visceromotor and nociceptive responses to rectal distension before and during experimental colitis in rats * , 1994, Fundamental & clinical pharmacology.

[69]  K. Nichols,et al.  [3H]GABA uptake and GABA localization in mucosal endocrine cells of the rat stomach and colon. , 1994, Journal of the autonomic nervous system.

[70]  F. Amenta,et al.  Autoradiographic localization of [3H]muscimol binding sites in rat stomach: evidence for mucosal GABAA receptors. , 1990, European journal of pharmacology.

[71]  T. Burks,et al.  Stress-induced changes in intestinal transit in the rat: a model for irritable bowel syndrome. , 1988, Gastroenterology.

[72]  Rémi Brazeilles,et al.  Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome. , 2017, Gastroenterology.

[73]  O. Snead,et al.  GABA, γ‐hydroxybutyric acid, and neurological disease , 2003 .

[74]  M. Nomura,et al.  Novel characteristic for distinguishing Lactococcus lactis subsp. lactis from subsp. cremoris. , 1999, International journal of systematic bacteriology.

[75]  C. Ribak.  Gabaergic mechanisms in the mammalian periphery. Edited by Sándor L. Erdö and Norman G. Bowery. Raven Press, New York, 1986 , 1988 .

[76]  N. Bowery,et al.  GABAergic mechanisms in the mammalian periphery , 1986 .